National Action Plan For The MHPSS Response To COVID-19

National Action Plan for the MHPSS Response to COVID-19

This action plan was developed as part of the national response to the COVID-19 outbreak. It aims at comprehensively addressing the MHPSS aspects of the COVID-19 outbreak in Lebanon for all persons living in the country. It was developed by the MOPH-National Mental Health Programme (NMHP) with WHO and UNICEF, in line with the IASC Briefing note on addressing mental health and psychosocial aspects of COVID-19 Outbreak- version 1.0 and the local needs, health system and national mental health strategy.

Goals:

Promote mental health and mitigate COVID-19 related stressors including stigma and discrimination against persons affected and health workers.
Provide mental health support to the persons in quarantine in the hospital or at home and their families.
Support the mental health of health workers and first responders in the response.
Ensure continuity of mental health care for persons using mental health services in line with IPC guidelines.

To view the action plan, click here: National Action Plan for MHPSS Response to COVID-19

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
N06DX01	EBIXA	B	Memantine - 20mg	20mg	Tablet, film coated	4,004,651 L.L
L01XJ01	ERIVEDGE	B	Vismodegib - 150mg	150mg	Capsule	465,368,012 L.L
A10BD21	ENFORZA	B	Saxagliptin HCl - 5mg, Dapagliflozin - 10mg		Tablet, film coated	6,072,824 L.L
L01AA01	ENDOXAN	B	Cyclophosphamide (monohydrate) - 500mg	500mg	Injectable powder for solution	L.L
J05AP55	EPCLUSA	B	Sofosbuvir - 400mg, Velpatasvir - 100mg		Tablet, film coated	991,921,769 L.L
D07AC13	ELOCOM	B	Mometasone furoate - 1mg/g	0.1%	Lotion	282,207 L.L
B01AF02	ELIQUIS	B	Apixaban - 5mg	5mg	Tablet, film coated	4,183,603 L.L
R05CB01	EXOMUC	B	N-acetylcysteine - 200mg	200mg	Granules for solution	529,474 L.L
B01AF02	ELIQUIS	B	Apixaban - 2.5mg	2.5mg	Tablet, film coated	4,183,603 L.L
C03AA03	ESIDREX	B	Hydrochlorothiazide - 25mg	25mg	Tablet	380,115 L.L
A07BA51	EUCARBON	B	Rhubarbe - 25mg, Sulfur - 50mg, Senna - 105mg, Vegetal charcoal - 180mg		Tablet	795,555 L.L
B02AA02	EXACYL	B	Tranexamic acid - 500mg/5ml	500mg/5ml	Injectable solution	748,520 L.L
N03AB02	EPANUTIN	B	Phenytoin sodium - 100mg	100mg	Capsule	739,113 L.L
N03AB02	EPANUTIN	B	Phenytoin sodium - 100mg	100mg	Capsule	739,113 L.L
M09AX10	EVRYSDI	B	Risdiplam - 0.75mg/ml	0.75mg/ml	Powder	865,644,067 L.L
L02BB05	ERLEADA	B	Apalutamide - 60mg	60mg	Tablet, film coated	264,151,186 L.L
D10AD53	EPIDUO	B	Adapalene - 0.1%, Benzoyl peroxide - 2.5%		Gel	2,088,331 L.L
D10AD53	EPIDUO FORTE	B	Adapalene - 0.3%, Benzoyl peroxide - 2.5%		Gel	2,201,214 L.L
J07BC01	ENGERIX-B 20	B	Hepatitis B, purified antigen - 20mcg/ml	20mcg/ml	Injectable suspension	1,652,926 L.L
D10AF02	ERYFLUID	B	Erythromycin base - 40mg/ml	4%	Lotion	542,912 L.L
J07BC01	ENGERIX-B 10	B	Hepatitis B, surface antigen - 10mcg/0.5ml	10mcg/0.5ml	Injectable suspension	1,042,822 L.L
D10AF02	ERYFLUID	B	Erythromycin base - 4%	4%	Lotion	542,912 L.L
N01BB54	EMLA	B	Prilocaine - 25mg/g, Lidocaine - 25mg/g	5%	Cream	1,763,121 L.L
B05DA	EXTRANEAL (ICODEXTRIN 7.5%) TWIN BAG	B	Sodium lactate - 4.5g/l, Magnesium Chloride - 0.051g/l, Calcium chloride - 0.257g/l, Sodium chloride - 5.4g/l, Icodextrin - 75.0 g/l		Injectable solution	1,998,025 L.L
B05DA	EXTRANEAL (ICODEXTRIN 7.5%) SINGLE BAG	B	Sodium lactate - 4.5g/l, Magnesium Chloride - 0.051g/l, Calcium chloride - 0.257g/l, Sodium chloride - 5.4g/l, Icodextrin - 75.0 g/l		Injectable solution	1,998,025 L.L
C09CA09	EDARBI	B	Azilsartan medoxomil - 40mg	40mg	Tablet	1,846,440 L.L
C09CA09	EDARBI	B	Azilsartan medoxomil - 80mg	80mg	Tablet	2,023,827 L.L
L01AA01	ENDOXAN	B	Cyclophosphamide (monohydrate) - 500mg	500mg	Injectable powder for solution	764,646 L.L
L01AA01	ENDOXAN	B	Cyclophosphamide (monohydrate) - 500mg	500mg	Injectable powder for solution	764,646 L.L
C10AX09	EZETROL	B	Ezetimibe - 10mg	10mg	Tablet	3,680,849 L.L

...